Efficacy of 3 Tesla functional magnetic stimulation for the treatment of female urinary incontinence

Braga, Andrea; Castronovo, Fabiana; Caccia, Giorgio; Papadia, Andrea; Regusci, Luca; Torella, Marco; Salvatore, Stefano; Scancarello, Chiara; Ghezzi, Fabio; Serati, Maurizio

doi:10.3390/jcm11102805

Back

Journal article

Efficacy of 3 Tesla functional magnetic stimulation for the treatment of female urinary incontinence

Braga, Andrea ORCID Department of Obstetrics and Gynecology, EOC—Beata Vergine Hospital, Mendrisio, Switzerland ; Faculty of Biomedical Sciences, Università della Svizzera italiana, Switzerland
Castronovo, Fabiana Department of Obstetrics and Gynecology, EOC—Beata Vergine Hospital, Mendrisio, Switzerland
Caccia, Giorgio Department of Obstetrics and Gynecology, EOC—Beata Vergine Hospital, Mendrisio, Switzerland
Papadia, Andrea Faculty of Biomedical Sciences, Università della Svizzera italiana, Switzerland ; Department of Obstetrics and Gynecology, EOC—Civico Hospital, Lugano, Switzerland
Regusci, Luca Department of General Surgery, EOC—Beata Vergine Hospital, Mendrisio, Switzerland
Torella, Marco Department of Gyanecology, Obstetric and Reproductive Science, Second University of Naples, Naples, Italy
Salvatore, Stefano Department of Obstetrics and Gynecology, IRCSS San Raffaele Scientific Institute, Milan, Italy
Scancarello, Chiara Department of Obstetrics and Gynecology, Del Ponte Hospital, University of Insubria, Varese, Italy
Ghezzi, Fabio Department of Obstetrics and Gynecology, Del Ponte Hospital, University of Insubria, Varese, Italy
Serati, Maurizio Department of Obstetrics and Gynecology, Del Ponte Hospital, University of Insubria, Varese, Italy

2022

Published in:

Journal of clinical medicine. - 2022, vol. 11, p. 2805

Functional magnetic stimulation

Extracorporeal magnetic innervation

English Functional magnetic stimulation (FMS) is a new technique for the conservative treatment ofUrinary incontinence (UI), based on magnetic induction. It induces controlled depolarization of thenerves, resulting in pelvic muscle contraction and sacral S2-S4 roots neuromodulation. The aim of thisstudy was to assess the efficacy of the new 3 Tesla FMS chair, both in patients with pure stress urinaryincontinence (SUI) and in women with pure overactive bladder (OAB) symptoms. A prospectiveobservational study was conducted in our urogynaecologic unit. All the patients involved wereconsecutive women with pure SUI or pure OAB symptoms treated by a 3 Tesla electromagneticchair. The primary outcome was a subjective outcome evaluation by the PGI-I Scale and a patient-satisfaction scale. The secondary outcome was the change score of the UDI-6, IIQ-7, ICIQ-SF andOAB-q SF questionnaires from baseline to final visit. At 2 months follow-up, 28 out of 60 patients(47%) with SUI symptoms and 20 out of 40 patients (50%) with OAB symptoms declared themselvescured. Considering cured and improved patients, the subjective cure rates were 68.3% (41/60) and70% (28/40) for patients with SUI and OAB symptoms, respectively. The results of this study showedthat the 3 Tesla electromagnetic chair may be an effective option for the treatment of UI.

Collections